← Back to Search

Non-invasive Device

BTL-785-7 for Wrinkles

N/A
Waitlist Available
Research Sponsored by BTL Industries Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 months
Awards & highlights

Study Summary

This trial will study a new, non-invasive facial remodeling system to see how safe and effective it is.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Non-invasive facial remodeling
Secondary outcome measures
Evaluation of skin quality and aesthetic change of the treated areas after the therapies
Subject Satisfaction
Therapy Comfort

Trial Design

1Treatment groups
Experimental Treatment
Group I: Non-invasive facial remodelingExperimental Treatment1 Intervention
Treatment with the BTL-785-7 applicator to the BTL-785F system.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BTL-785-7
2023
N/A
~110

Find a Location

Who is running the clinical trial?

BTL Industries Ltd.Lead Sponsor
51 Previous Clinical Trials
1,778 Total Patients Enrolled
12 Trials studying Wrinkles
353 Patients Enrolled for Wrinkles

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025